Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma
F Foss, B Pro, H Miles Prince, L Sokol… - Cancer …, 2017 - Wiley Online Library
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous group of aggressive non‐Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
[PDF][PDF] Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
F Foss, B Pro, HM Prince, L Sokol, D Caballero… - 2016 - cyberleninka.org
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.
F Foss, B Pro, L Sokol, D Caballero, S Horwitz… - Cancer …, 2016 - europepmc.org
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous group of aggressive non‐Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
[HTML][HTML] Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma
F Foss, B Pro, HM Prince, L Sokol, D Caballero… - Cancer …, 2017 - ncbi.nlm.nih.gov
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous group of aggressive non‐Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
F Foss, B Pro, HM Prince, L Sokol… - Cancer …, 2017 - scholars.northwestern.edu
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
[PDF][PDF] Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
F Foss, B Pro, HM Prince, L Sokol, D Caballero… - Cancer …, 2017 - academia.edu
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
F Foss, B Pro, HM Prince, L Sokol… - Cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
[引用][C] Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
F Foss, B Pro, HM Prince, L Sokol, D Caballero… - Cancer Medicine, 2016 - cir.nii.ac.jp
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral
T-cell lymphoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
T-cell lymphoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma
F Foss, B Pro, HM Prince, L Sokol… - Cancer …, 2017 - search.proquest.com
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous group of aggressive non‐Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.
F Foss, B Pro, H Miles Prince, L Sokol… - Cancer …, 2017 - search.ebscohost.com
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …